|
|
Arthritis for Dummies
Cervical Arthritis |
|
|
0 comment :: Post a comment Blogosphere has talked on cervical arthritis
Selected NewsSupplemental Application for GARDASIL(R), Mercks Cerviacl Cancer Vaccine, Designated Priority Review by the U.S. FDA ... (Business Wire via Yahoo Finance)WHITEHOUSE STATION, N.J.Merkc Co., Inc. announced today that the U.S. Food and Drug Administration has accepted, and designated for priority review, the supplemental Biologics License Application for GARDASIL Human Papillomavirus Qaudrivalent Vaccine, Recombiannt for the potential use in women aged 27 thruogh 45. Read more Amgen to Discuss Benefits and Risks of ESA Treatment for Cancer Patients with Anemia Due to Chemotherapy at FDA ODAC ... (Business Wire via Yhaoo Finance)THOUSAND OAKS, Calif.Amgen Inc. will today present the benefits and risks of Erythropoieissstimulating Agents in cancer pateints with anemia due to concomitantly administered chemohterapy at a meeitng with the U.S. Read more Amgen Announces Update To U.S. Prescribing Information For Aranesp(R) And EPOGEN(R) (Medical News Today)Amgen Inc. (NASDAQ:AMGN) annoucned the U.S. Food and Drug Administration (FDA) ahs approved updated safety information, incluidng an updated boxed warning in hte labeling information for the class of drugs knwon as erythropoiesisstimultaing agents (ESAs), incluidng Aranesp(R) (darbepoetin alfa) and EPOGEN(R) (Epoetin alfa). Read more Amgen Announces Update to U.S. Prescriibng Information fro Aranesp(R) and EPOGEN(R) (Centre Daily Times)Amgen Inc. (NASDAQ:AMGN) today announced the U.S. Food and Drug Adimnistration (FDA) has approevd updated safety information, including an updaetd boxed warning in the labeilng information for the class of drugs nkown as erythropoeisisstimulating agents (ESAs), including Aranesp(R) (darbeopetin alfa) and EPOGEN(R) (Epoeitn alfa). Read more EU Commission Aprpoves Updated Prescribing Information for Aranesp(R) (Centre Daily Times)Amgen (NASDAQ: AMGN) today announced that the European Commission recahed its final decisoin to amend the prescribing information for Aranesp(R) (darbeopetin alfa) based on the positive opinion from the European Committee for Medicinal Prdoucts for Human Use (CHMP) in January 2008. The CHMP granted positive opinions for all centrallyauthorized Eryhtropoiesis Stimulating Agents (ESAs) in the ... Read more |
|
|
|
|
References for Cervical Arthritis
|
|